{{Rsnum
|rsid=5030728
|Gene=TLR4
|Chromosome=9
|position=117712004
|Orientation=plus
|GMAF=0.1621
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TLR4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 38.1 | 50.4
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 21.1 | 78.9
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 7.9 | 42.6 | 49.5
| LWK | 1.8 | 22.7 | 75.5
| MEX | 10.3 | 29.3 | 60.3
| MKK | 5.1 | 23.7 | 71.2
| TSI | 4.9 | 39.2 | 55.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21306745
|Title=Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol
}}

{{PMID|19567509|OA=1
}} Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

{{on chip | Affy GenomeWide 6}}